TLR2 |
Immune cell receptor, promotes cytokine production through NFkB pathway, improve chemotherapy |
34.3 |
(Garay et al., 2007) |
IFNG |
Immune cytokine, inhibits breast cancer proliferation |
16 |
(Iacopino et al., 1997) |
IFNB1 |
Immune cytokine, inhibits breast cancer proliferation |
10.6 |
(Sica et al., 1987) |
NR2C2/TR4 |
Orphan nuclear receptor |
8 |
(Shyr et al., 2002) |
PELI1 |
E3 ubiquitin ligase, promotes cytokine synthesis |
7.5 |
(Chang et al., 2009) |
REL |
a member of the NFκB family of transcription factors. |
6.5 |
(Biswas et al., 2004) |
CD180 |
a member of the Toll-like receptors |
6.1 |
(Aderem and Ulevitch, 2000) |
MAPK8IP3 |
protein kinase, regulates the activity of numerous protein kinases of the JNK signaling pathway |
5.3 |
(Davis, 2000) |
CSF2/GM- CSF |
Anti-tumorigenic cytokine in breast cancer |
4.9 |
(Eubank et al., 2009) |
MAP4K4 |
Protein kinase, upregulated p53 and drives c- Jun NH2-terminal kinase (JNK) Mediated apoptosis |
4.0 |
(Miled et al., 2005) |
IL1B |
Inflammatory cytokine, promotes leukocyte differentiation, inhibits breast proliferation |
4.0 |
(Roy et al., 2006) |
c-FOS |
Proto-oncogene important in breast cancer proliferation |
4.0 |
(van der Burg et al., 1989) |